ODOR CONTROL POWDER SPRAY

ODOR CONTROL POWDER SPRAY was reported 188 times

ODOR CONTROL POWDER SPRAY is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MICRODONTIA 1 0.2500
1 URAEMIA ODOUR 1 0.1250
2 BRONCHITIS PNEUMOCOCCAL 1 0.0476
3 TOOTH HYPOPLASIA 8 0.0460
4 CHEST SCAN ABNORMAL 1 0.0303
5 ENAMEL ANOMALY 8 0.0280
6 SARCOMATOID MESOTHELIOMA 1 0.0133
7 ABDOMINAL WALL CYST 1 0.0082
8 BLADDER CYST 1 0.0062
9 SCHWANNOMA 1 0.0050
10 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 7 0.0050
11 MUCORMYCOSIS 11 0.0042
12 MORAXELLA INFECTION 1 0.0036
13 NERVE ROOT COMPRESSION 2 0.0035
14 ABDOMINAL WALL DISORDER 1 0.0034
15 MALOCCLUSION 1 0.0034
16 POSITIVE AIRWAY PRESSURE THERAPY 1 0.0034
17 HAEMATOLOGY TEST ABNORMAL 1 0.0031
18 CHRONIC RESPIRATORY DISEASE 1 0.0028
19 VAGINAL FISTULA 1 0.0028
20 CANCER PAIN 7 0.0027
21 LUNG CYST 1 0.0025
22 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 7 0.0025
23 PSEUDOMONAS TEST POSITIVE 2 0.0024
24 FUNGAL FOOT INFECTION 1 0.0023
25 CARBON DIOXIDE INCREASED 3 0.0022
26 GALLBLADDER RUPTURE 1 0.0022
27 TUBERCULOUS PLEURISY 1 0.0021
28 CHRONIC GRAFT VERSUS HOST DISEASE 7 0.0019
29 BLOOD IMMUNOGLOBULIN M INCREASED 1 0.0016
30 DRY GANGRENE 1 0.0016
31 MESOTHELIOMA 2 0.0015
32 BRONCHOPULMONARY ASPERGILLOSIS 11 0.0014
33 JUDGEMENT IMPAIRED 2 0.0014
34 HEAT EXHAUSTION 1 0.0012
35 SPUTUM CULTURE POSITIVE 1 0.0012
36 EXPOSURE TO CHEMICAL POLLUTION 2 0.0012
37 RELAPSING-REMITTING MULTIPLE SCLEROSIS 1 0.0012
38 RED BLOOD CELL COUNT INCREASED 3 0.0011
39 DENTAL CARE 2 0.0011
40 PHARYNGEAL HYPOAESTHESIA 1 0.0011
41 TELANGIECTASIA 1 0.0010
42 HYPERVIGILANCE 1 0.0010
43 REDUCED FACIAL EXPRESSION 1 0.0010
44 BLOOD CREATININE DECREASED 3 0.0010
45 STAPHYLOCOCCUS TEST POSITIVE 2 0.0009
46 PO2 DECREASED 1 0.0009
47 CHEMICAL BURN 1 0.0009
48 GROIN ABSCESS 1 0.0008
49 DEVICE DISPENSING ERROR 1 0.0008
50 GLUCOSE URINE PRESENT 1 0.0008
51 LIPOMA 2 0.0008
52 SINUS ARRHYTHMIA 1 0.0008
53 TUMOUR PAIN 1 0.0008
54 BLOOD POTASSIUM INCREASED 12 0.0007
55 RASH MORBILLIFORM 2 0.0007
56 CONTRAINDICATION TO MEDICAL TREATMENT 1 0.0007
57 URINE KETONE BODY PRESENT 1 0.0006
58 OEDEMA MOUTH 2 0.0006
59 METABOLIC SYNDROME 1 0.0006
60 ANTIBODY TEST POSITIVE 1 0.0006
61 CERVICAL SPINAL STENOSIS 1 0.0006
62 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 3 0.0006
63 PNEUMONIA KLEBSIELLA 1 0.0005
64 INJECTION SITE CELLULITIS 1 0.0005
65 TRAUMATIC LUNG INJURY 1 0.0005
66 LATENT TUBERCULOSIS 1 0.0005
67 ABSCESS LIMB 2 0.0005
68 TOOTH DISORDER 10 0.0004
69 HAEMATOCRIT INCREASED 1 0.0004
70 GRAFT VERSUS HOST DISEASE 3 0.0004
71 WRONG DOSE 1 0.0004
72 BREATH ODOUR 1 0.0004
73 HYPERVOLAEMIA 2 0.0004
74 INJECTION SITE ABSCESS 1 0.0004
75 SKIN LESION 11 0.0004
76 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1 0.0004
77 TEMPOROMANDIBULAR JOINT SYNDROME 1 0.0004
78 CHOLECYSTITIS INFECTIVE 1 0.0004
79 LUMBAR SPINAL STENOSIS 1 0.0003
80 CREPITATIONS 1 0.0003
81 BRONCHIECTASIS 2 0.0003
82 DEPRESSION SUICIDAL 1 0.0003
83 TACHYPHRENIA 1 0.0003
84 WOUND 8 0.0003
85 CARPAL TUNNEL SYNDROME 4 0.0003
86 THERMAL BURN 2 0.0003
87 PRODUCT CONTAMINATION 1 0.0003
88 CAROTID ARTERY OCCLUSION 1 0.0003
89 RASH ERYTHEMATOUS 13 0.0003
90 TENDON INJURY 1 0.0003
91 MUCOSAL INFLAMMATION 7 0.0003
92 PROTEIN TOTAL DECREASED 1 0.0003
93 CARDIOPULMONARY FAILURE 1 0.0003
94 PNEUMONIA FUNGAL 1 0.0003
95 FUNGAL SKIN INFECTION 1 0.0002
96 BLOOD UREA INCREASED 4 0.0002
97 BUNDLE BRANCH BLOCK LEFT 1 0.0002
98 CARDIAC FAILURE CHRONIC 1 0.0002
99 ATRIOVENTRICULAR BLOCK FIRST DEGREE 1 0.0002
100 PHYSICAL DISABILITY 1 0.0002
101 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
102 NERVE COMPRESSION 2 0.0002
103 BLOOD CHOLESTEROL ABNORMAL 1 0.0002
104 SPUTUM DISCOLOURED 2 0.0002
105 GUILLAIN-BARRE SYNDROME 1 0.0002
106 KNEE OPERATION 2 0.0002
107 DIABETIC NEUROPATHY 1 0.0002
108 PATHOLOGICAL FRACTURE 1 0.0002
109 C-REACTIVE PROTEIN INCREASED 7 0.0002
110 PHARYNGOLARYNGEAL PAIN 1 0.0002
111 INTERVERTEBRAL DISC PROTRUSION 4 0.0002
112 ASTHENOPIA 1 0.0002
113 CHOKING SENSATION 1 0.0002
114 DRUG LEVEL INCREASED 3 0.0002
115 PERONEAL NERVE PALSY 1 0.0002
116 HYPERTONIA 1 0.0002
117 PERIPHERAL SENSORY NEUROPATHY 1 0.0002
118 SINUS HEADACHE 1 0.0002
119 GANGRENE 1 0.0002
120 CYST 2 0.0002
121 OLIGURIA 1 0.0002
122 BLOOD ALKALINE PHOSPHATASE INCREASED 4 0.0002
123 PRE-EXISTING CONDITION IMPROVED 1 0.0002
124 SCREAMING 1 0.0002
125 ENTERITIS 1 0.0002
126 PLATELET COUNT INCREASED 2 0.0002
127 DYSGRAPHIA 1 0.0002
128 WALKING AID USER 1 0.0002
129 PROSTATIC SPECIFIC ANTIGEN INCREASED 2 0.0001
130 DISSEMINATED INTRAVASCULAR COAGULATION 2 0.0001
131 PAPULE 1 0.0001
132 FAECES SOFT 1 0.0001
133 BONE PAIN 8 0.0001
134 PULMONARY MASS 2 0.0001
135 ECONOMIC PROBLEM 2 0.0001
136 RENAL IMPAIRMENT 11 0.0001
137 RENAL FAILURE CHRONIC 1 0.0001
138 TENDONITIS 2 0.0001
139 DRUG SCREEN POSITIVE 1 0.0001
140 FURUNCLE 1 0.0001
141 BLOOD ALBUMIN DECREASED 1 0.0001
142 RENAL CYST 1 0.0001
143 SCIATICA 2 0.0001
144 DECUBITUS ULCER 1 0.0001
145 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
146 VITAMIN D DECREASED 1 0.0001
147 ERECTILE DYSFUNCTION 3 0.0001
148 SKIN HYPERPIGMENTATION 1 0.0001
149 GASTROINTESTINAL DISORDER 10 0.0001
150 LEUKOCYTOSIS 2 0.0001
151 LIP DRY 1 0.0001
152 END STAGE RENAL DISEASE 2 0.0001
153 RETINAL DETACHMENT 1 0.0001
154 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
155 HAEMOPTYSIS 3 0.0001
156 DEFORMITY 1 0.0001
157 PHOTOPHOBIA 2 0.0001
158 WHITE BLOOD CELL COUNT INCREASED 4 0.0001
159 SINUS BRADYCARDIA 1 0.0001
160 DYSSTASIA 3 0.0001
161 PARKINSONISM 1 0.0001
162 PHARYNGEAL SWELLING 1 0.0001
163 LIGAMENT SPRAIN 1 0.0001
164 EMPHYSEMA 1 0.0001
165 MOTOR DYSFUNCTION 1 0.0001
166 NEUTROPHIL COUNT INCREASED 1 0.0001
167 RIB FRACTURE 2 0.0001
168 TEMPERATURE INTOLERANCE 1 0.0001
169 POLLAKIURIA 4 0.0001
170 INCONTINENCE 1 0.0001
171 RENAL PAIN 1 0.0001
172 DECREASED ACTIVITY 1 0.0001
173 PHARYNGITIS STREPTOCOCCAL 1 0.0001
174 MICTURITION URGENCY 1 0.0001
175 MYOCARDITIS 1 0.0001
176 NEOPLASM 1 0.0001
177 SHOCK 2 0.0001
178 SPLENOMEGALY 1 0.0001
179 SEXUAL DYSFUNCTION 1 0.0001
180 NEUROLEPTIC MALIGNANT SYNDROME 1 0.0001
181 BLOOD IRON DECREASED 1 0.0001
182 ATAXIA 1 0.0001
183 WRIST FRACTURE 1 0.0001
184 HEPATITIS C 1 0.0001
185 NOCTURIA 1 0.0001
186 GENERALISED OEDEMA 1 0.0001
187 ANOREXIA 1 0.0001
188 PULMONARY CONGESTION 1 0.0001
189 QUALITY OF LIFE DECREASED 1 0.0001
190 OEDEMA 4 0.0001
191 LYMPHOPENIA 1 0.0001
192 PAIN IN JAW 2 0.0001
193 IMPAIRED QUALITY OF LIFE 1 0.0001
194 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
195 SKIN HAEMORRHAGE 1 0.0001
196 RENAL INJURY 2 0.0001
197 CATARACT 4 0.0001
198 CHRONIC KIDNEY DISEASE 5 0.0001
199 OEDEMA PERIPHERAL 8 0.0001
200 INSURANCE ISSUE 1 0.0001
201 ALANINE AMINOTRANSFERASE INCREASED 4 0.0001
202 PHARYNGEAL OEDEMA 1 0.0001
203 THYROID DISORDER 1 0.0001
204 MUSCULOSKELETAL CHEST PAIN 1 0.0001
205 ANKLE FRACTURE 1 0.0001
206 LUNG INFECTION 1 0.0001
207 COGNITIVE DISORDER 3 0.0001
208 SWOLLEN TONGUE 2 0.0001
209 PRODUCT USE COMPLAINT 1 0.0001
210 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
211 PRODUCTIVE COUGH 3 0.0001
212 CYSTITIS 2 0.0001
213 OBESITY 1 0.0001
214 IMPAIRED HEALING 2 0.0001
215 MULTIPLE FRACTURES 1 0.0001
216 TYPE 2 DIABETES MELLITUS 2 0.0001
217 FACE OEDEMA 1 0.0001
218 DISEASE PROGRESSION 7 0.0001
219 ACUTE KIDNEY INJURY 9 0.0001
220 SCAR 1 0.0001
221 HYPERKALAEMIA 2 0.0001
222 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
223 BRADYCARDIA 3 0.0001
224 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
225 RASH PRURITIC 3 0.0001
226 HEPATIC STEATOSIS 1 0.0001
227 NECK PAIN 3 0.0001
228 BACTERIAL INFECTION 1 0.0001
229 HEPATIC CIRRHOSIS 1 0.0001
230 FLATULENCE 3 0.0001
231 BLOOD URINE PRESENT 1 0.0001
232 DIABETES MELLITUS 4 0.0001
233 SLEEP APNOEA SYNDROME 1 0.0001
234 ACUTE RESPIRATORY FAILURE 1 0.0001
235 PRESCRIBED OVERDOSE 1 0.0001
236 KIDNEY INFECTION 1 0.0001
237 DISABILITY 1 0.0001
238 SINUS DISORDER 1 0.0001
239 BLOOD PRESSURE ABNORMAL 1 0.0001
240 UPPER LIMB FRACTURE 1 0.0001
241 PRODUCT ADMINISTRATION ERROR 1 0.0000
242 PERITONITIS 1 0.0000
243 HALLUCINATION, VISUAL 1 0.0000
244 EATING DISORDER 1 0.0000
245 IRRITABLE BOWEL SYNDROME 1 0.0000
246 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
247 AMNESIA 3 0.0000
248 PRODUCT DISPENSING ERROR 1 0.0000
249 MUSCULOSKELETAL STIFFNESS 4 0.0000
250 APPLICATION SITE PAIN 1 0.0000
251 ANGIOEDEMA 2 0.0000
252 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
253 COLITIS ULCERATIVE 2 0.0000
254 BACK PAIN 10 0.0000
255 BLOOD CHOLESTEROL INCREASED 2 0.0000
256 BURNING SENSATION 3 0.0000
257 LOCALISED INFECTION 1 0.0000
258 NEURALGIA 1 0.0000
259 ARTHRALGIA 17 0.0000
260 LUNG DISORDER 2 0.0000
261 LIVER INJURY 1 0.0000
262 ABASIA 1 0.0000
263 AGEUSIA 1 0.0000
264 HYPOPHAGIA 1 0.0000
265 HEPATITIS 1 0.0000
266 SINUSITIS 4 0.0000
267 DRUG RESISTANCE 1 0.0000
268 SKIN ULCER 1 0.0000
269 RASH GENERALISED 1 0.0000
270 PHARMACEUTICAL PRODUCT COMPLAINT 1 0.0000
271 DIPLOPIA 1 0.0000
272 RESPIRATORY TRACT INFECTION 1 0.0000
273 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
274 ARTHRITIS 3 0.0000
275 ANHEDONIA 1 0.0000
276 DRUG INTERACTION 6 0.0000
277 PNEUMONITIS 1 0.0000
278 MENTAL STATUS CHANGES 1 0.0000
279 URTICARIA 6 0.0000
280 BLISTER 2 0.0000
281 TARDIVE DYSKINESIA 1 0.0000
282 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
283 DEPRESSION 8 0.0000
284 HYPERSOMNIA 1 0.0000
285 BALANCE DISORDER 3 0.0000
286 ASCITES 1 0.0000
287 LABORATORY TEST ABNORMAL 1 0.0000
288 URINARY INCONTINENCE 1 0.0000
289 SWELLING 3 0.0000
290 HEAD INJURY 1 0.0000
291 NEUROPATHY PERIPHERAL 3 0.0000
292 METABOLIC ACIDOSIS 1 0.0000
293 HIP FRACTURE 1 0.0000
294 RHINORRHOEA 2 0.0000
295 PNEUMONIA 10 0.0000
296 EYE DISORDER 1 0.0000
297 RENAL FAILURE 4 0.0000
298 LIP SWELLING 1 0.0000
299 FUNGAL INFECTION 1 0.0000
300 SKIN DISORDER 1 0.0000
301 URINARY RETENTION 1 0.0000
302 GAIT INABILITY 1 0.0000
303 CHEST DISCOMFORT 3 0.0000
304 ERYTHEMA 6 0.0000
305 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
306 NIGHTMARE 1 0.0000
307 RASH MACULAR 1 0.0000
308 HYPOXIA 1 0.0000
309 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
310 MOBILITY DECREASED 2 0.0000
311 DRUG EFFECT INCOMPLETE 1 0.0000
312 HYPERGLYCAEMIA 1 0.0000
313 UNDERDOSE 2 0.0000
314 ACCIDENTAL OVERDOSE 1 0.0000
315 DYSURIA 1 0.0000
316 DYSARTHRIA 1 0.0000
317 INTESTINAL OBSTRUCTION 1 0.0000
318 UNEVALUABLE EVENT 2 0.0000
319 INJECTION SITE SWELLING 2 0.0000
320 PERIPHERAL SWELLING 4 0.0000
321 ABNORMAL BEHAVIOUR 1 0.0000
322 JOINT SWELLING 3 0.0000
323 DIARRHOEA 16 0.0000
324 EXTRA DOSE ADMINISTERED 1 0.0000
325 DRY MOUTH 2 0.0000
326 DYSKINESIA 1 0.0000
327 BLINDNESS 1 0.0000
328 NEUTROPHIL COUNT DECREASED 1 0.0000
329 OSTEOPOROSIS 1 0.0000
330 PRODUCT USE IN UNAPPROVED INDICATION 6 0.0000
331 VISUAL IMPAIRMENT 3 0.0000
332 RHABDOMYOLYSIS 1 0.0000
333 MYALGIA 4 0.0000
334 PRURITUS 9 0.0000
335 SEPTIC SHOCK 1 0.0000
336 DEHYDRATION 3 0.0000
337 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
338 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4 0.0000
339 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
340 SKIN IRRITATION 1 0.0000
341 SKIN DISCOLOURATION 1 0.0000
342 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
343 HYPERSENSITIVITY 4 0.0000
344 RENAL DISORDER 1 0.0000
345 VOMITING 10 0.0000
346 ARRHYTHMIA 1 0.0000
347 OCULAR HYPERAEMIA 1 0.0000
348 GAIT DISTURBANCE 4 0.0000
349 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
350 HEADACHE 13 0.0000
351 HYPOGLYCAEMIA 1 0.0000
352 ATRIAL FIBRILLATION 2 0.0000
353 PAIN IN EXTREMITY 6 0.0000
354 DYSPEPSIA 2 0.0000
355 HEART RATE INCREASED 2 0.0000
356 DRY EYE 1 0.0000
357 LEUKOPENIA 1 0.0000
358 AGGRESSION 1 0.0000
359 HYPOTENSION 4 0.0000
360 THERAPY CESSATION 1 0.0000
361 DYSPNOEA 11 0.0000
362 PANCREATITIS 1 0.0000
363 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
364 DISTURBANCE IN ATTENTION 1 0.0000
365 RASH 8 0.0000
366 CONSTIPATION 4 0.0000
367 TREATMENT NONCOMPLIANCE 1 0.0000
368 TREMOR 3 0.0000
369 HYPONATRAEMIA 1 0.0000
370 ANXIETY 5 0.0000
371 ABDOMINAL PAIN 4 0.0000
372 PALPITATIONS 2 0.0000
373 CHILLS 2 0.0000
374 SURGERY 1 0.0000
375 WHEEZING 1 0.0000
376 FATIGUE 13 0.0000
377 SUICIDE ATTEMPT 1 0.0000
378 STOMATITIS 1 0.0000
379 CONDITION AGGRAVATED 5 0.0000
380 PLEURAL EFFUSION 1 0.0000
381 VERTIGO 1 0.0000
382 DISCOMFORT 1 0.0000
383 DEEP VEIN THROMBOSIS 1 0.0000
384 SWELLING FACE 1 0.0000
385 BLOOD CREATININE INCREASED 1 0.0000
386 INFUSION RELATED REACTION 1 0.0000
387 FALL 5 0.0000
388 INSOMNIA 4 0.0000
389 INJECTION SITE PRURITUS 1 0.0000
390 NEUTROPENIA 2 0.0000
391 ABDOMINAL PAIN UPPER 3 0.0000
392 VISION BLURRED 2 0.0000
393 MEMORY IMPAIRMENT 2 0.0000
394 INJECTION SITE REACTION 1 0.0000
395 SLEEP DISORDER 1 0.0000
396 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
397 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
398 PRODUCT DOSE OMISSION ISSUE 4 0.0000
399 BRONCHITIS 1 0.0000
400 EPISTAXIS 1 0.0000
401 HYPOAESTHESIA 2 0.0000
402 ASTHENIA 5 0.0000
403 BLOOD PRESSURE INCREASED 2 0.0000
404 HOSPITALISATION 2 0.0000
405 NAUSEA 10 0.0000
406 OFF LABEL USE 11 0.0000
407 INJECTION SITE HAEMORRHAGE 1 0.0000
408 THROMBOSIS 1 0.0000
409 INFLUENZA LIKE ILLNESS 1 0.0000
410 DIZZINESS 6 0.0000
411 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
412 ABDOMINAL DISCOMFORT 2 0.0000
413 URINARY TRACT INFECTION 2 0.0000
414 PYREXIA 4 0.0000
415 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
416 DRUG WITHDRAWAL SYNDROME 1 0.0000
417 ADVERSE DRUG REACTION 1 0.0000
418 NASOPHARYNGITIS 2 0.0000
419 PRODUCT USE ISSUE 2 0.0000
420 BLOOD GLUCOSE INCREASED 2 0.0000
421 PAIN 6 0.0000
422 HAEMOGLOBIN DECREASED 1 0.0000
423 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
424 HAEMORRHAGE 1 0.0000
425 PLATELET COUNT DECREASED 1 0.0000
426 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
427 MALAISE 4 0.0000
428 INFLUENZA 1 0.0000
429 SEPSIS 1 0.0000
430 WEIGHT INCREASED 2 0.0000
431 MUSCULAR WEAKNESS 1 0.0000
432 SEIZURE 1 0.0000
433 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
434 DECREASED APPETITE 2 0.0000
435 EMOTIONAL DISTRESS 1 0.0000
436 INJECTION SITE ERYTHEMA 1 0.0000
437 HYPERHIDROSIS 1 0.0000
438 PRODUCT QUALITY ISSUE 1 0.0000
439 WEIGHT DECREASED 2 0.0000
440 COUGH 2 0.0000
441 DRUG INEFFECTIVE 8 0.0000
442 CEREBROVASCULAR ACCIDENT 1 0.0000
443 COVID-19 1 0.0000
444 NO ADVERSE EVENT 1 0.0000
445 MUSCLE SPASMS 1 0.0000
446 CHEST PAIN 1 0.0000
447 HYPERTENSION 1 0.0000
448 FEELING ABNORMAL 1 0.0000
449 DEATH 3 0.0000
450 INJECTION SITE PAIN 1 0.0000